Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition	St. Jude Children’s Research Hospital / Adam Durbin, PhD	Young Investigator Grants	2018	Tennessee
NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia	St. Jude Children’s Research Hospital / Takaya Moriyama, MD/PhD	Young Investigator Grants	2018	Tennessee
Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients	Vanderbilt University Medical Center / Rachael Schulte, MD	Young Investigator Grants	2018	Tennessee
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML	Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD	Young Investigator Grants	2018	Massachusetts
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy	Fred Hutchinson Cancer Research Center / Colin Godwin, MD	Young Investigator Grants	2018	Washington
Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant	Children’s Hospital of Philadelphia / Caitlin Elgarten, MD	Young Investigator Grants	2018	Pennsylvania
RNA-ECS to Quantify Rare Clonal RNA Species at Diagnosis, Remission and Relapse from the COG AAML1031 Study	Washington University / Todd Druley, MD/PhD	Innovation Grants	2018	Missouri
Is SIRT5 a Therapy Target in Acute Lymphoblastic Leukemia?	University of Utah / Michael Deininger, MD/PhD	Innovation Grants	2018	Utah
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma	Baylor College of Medicine / Jason Yustein, MD/PhD	Innovation Grants	2018	Texas
Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity	University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD	Innovation Grants	2018	Texas

Pages